HOB Biotech Group Corp Ltd (688656) — Cash Flow-to-Debt Ratio
HOB Biotech Group Corp Ltd (688656) has a Cash Flow-to-Debt Ratio of 0.14x as of December 2025, meaning its operating cash flow of CN¥15.28 Million could theoretically repay 0% of its total liabilities (CN¥111.30 Million) in one year. Check 688656 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
HOB Biotech Group Corp Ltd Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for HOB Biotech Group Corp Ltd across 10 annual periods. Also explore 688656 asset base for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for HOB Biotech Group Corp Ltd (2016–2025)
Year-by-year debt coverage analysis for HOB Biotech Group Corp Ltd. For market capitalisation and broader financial context, see 688656 company net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.66x | CN¥72.94 Million | CN¥111.30 Million | ▲ +42.9% |
| 2024 | 0.46x | CN¥101.22 Million | CN¥220.67 Million | ▼ -38.1% |
| 2023 | 0.74x | CN¥102.69 Million | CN¥138.52 Million | ▲ +109.8% |
| 2022 | 0.35x | CN¥58.31 Million | CN¥164.99 Million | ▼ -68.3% |
| 2021 | 1.12x | CN¥104.79 Million | CN¥93.92 Million | ▲ +72.5% |
| 2020 | 0.65x | CN¥58.22 Million | CN¥90.02 Million | ▲ +25.9% |
| 2019 | 0.51x | CN¥68.57 Million | CN¥133.54 Million | ▲ +1.7% |
| 2018 | 0.50x | CN¥46.51 Million | CN¥92.10 Million | ▲ +47.9% |
| 2017 | 0.34x | CN¥22.26 Million | CN¥65.20 Million | ▲ +261.2% |
| 2016 | 0.09x | CN¥6.42 Million | CN¥67.94 Million | — |